Clinic Follow-Up Automation Checklist

A clinic follow-up automation checklist should end with a defensible decision: which exact workflow may be enabled, who authorises that decision, what evidence supports it and what will happen if a required control fails. A page of ticks is insufficient when no one can identify the version, patient scope or message channel that was tested.

Use this release checklist after the clinic has selected and prepared a defined follow-up workflow. It is an operational template to adapt with the responsible clinical, privacy, security and service teams. It does not certify a product or replace professional decisions about care, lawful processing or the clinic’s applicable requirements.

Define the release before assessing whether it can proceed

Create a release record with a unique reference, date, accountable owner and the exact workflow version. Identify the participating service, sites, user roles, approved patient scope, systems, message channels and permitted actions. Specify whether the activity is a simulation, an approved limited pilot or a wider operational release.

List what changes from the previously accepted process. A new message provider, model, recipient rule or clinical template may affect evidence that was valid for an older configuration. The release record should make those differences visible rather than inheriting an unrestricted “approved” label.

Link the current preparation evidence, but confirm that it still matches the proposed deployment. A plan to finish an integration or recruit a reviewer is not proof that the requirement exists on the day the workflow is enabled.

Give every check evidence, an owner and a blocking rule

Record the test or review performed, its result, the supporting evidence, the responsible reviewer and the date. Define what passes before running the check. If a requirement does not apply, document why and who accepted that conclusion; an empty cell is not an approved exclusion.

The NIST AI RMF Core addresses documented responsibilities, evaluation, monitoring and decisions about proceeding with deployment. It also states that its actions are not themselves a checklist. The release template here is a practical clinic-specific structure, not an official NIST checklist or Saudi compliance approval.

Use a small set of unambiguous outcomes: pass with evidence, blocked, or justified as not applicable. Record accepted residual issues separately with the authorised decision and scope. A cosmetic improvement can be scheduled later; an unresolved required identity or clinical-approval control should not disappear into a general backlog.

Use the release evidence table

Clinic follow-up release checks to complete for the actual configuration

Check	Evidence	Responsible role	Pass condition	Blocking condition
Intended use	Approved workflow and action list	Service owner with clinical lead	Every enabled action is within the agreed scope	An action has no approved purpose or decision boundary
Identity and recipient	Matching and changed-recipient tests	Operations and privacy owners	Only the verified appropriate recipient is used	Ambiguous identity or stale recipient can reach release
Source and approval	Task-to-instruction and revision tests	Clinical and operational reviewers	Current authorised instruction controls execution	A draft or superseded instruction can trigger action
Channel permission	Applicable rules and preference-change test	Privacy and channel owners	Required conditions and restrictions are applied	A required restriction is ignored by queued work
Integration state	Current-source, retry and conflict evidence	System owner	Technical events retain their correct meaning	Receipt is misrepresented as booking or completion
Clinical handover	Unavailable-recipient and cover rehearsal	Clinical service lead	Clinical concerns reach an accepted staffed route	No qualified receiving owner is available
Audit and access	Role tests and case reconstruction	Security and governance owners	Necessary events are traceable with limited access	Unauthorised access or missing action provenance
Stop and recovery	Pause, fallback and reconciled restart test	Release and service owners	Staff can stop affected actions and preserve obligations	Restart repeats stale actions or loses unresolved work

Expand rows where the actual pathway needs more than one test. Keep the evidence references specific enough for another authorised reviewer to inspect. A vendor slide saying a capability exists is not equivalent to a result from the proposed configuration.

Prove that the wrong action is stopped

Include cases that must not proceed: the wrong patient record, an unclear representative, a missing clinician condition, an unapproved clinical message and an outdated appointment. Define the expected hold, owner and explanation for each. A test that merely confirms a happy-path message can be sent does not establish these boundaries.

Inspect the work remaining after a hold. The legitimate obligation should stay visible with an authorised route for resolution. Blocking a message must not silently cancel care or erase the clinician’s requested follow-up. This distinguishes controlled prevention from simply discarding difficult cases.

Use fictional data for pre-release rehearsals wherever appropriate. Any evaluation involving real patient information needs its own approved arrangement. The task-review criteria help identify unsupported actions, but the release check must prove that the configured workflow honours the review outcome.

Test recipient restrictions in queued and repeated actions

Change a verified contact or channel preference after a message has been prepared. Check both the visible patient record and the stored job. The current permitted recipient and communication arrangement must govern release, including retries initiated after a temporary service failure.

Define the handling of a request to stop a channel without equating it to refusal of care. The responsible team should review any remaining care obligation and the appropriate alternative under the clinic’s process. Do not switch automatically to another channel unless its conditions and the actual arrangement allow that action.

A channel restriction that applies only to newly created messages is incomplete. Include scheduled work, failed-send retries and manual resend tools in the test scope. Record which components enforce the restriction and who resolves a mismatch between them.

Verify approval after the underlying instruction changes

Approve a fictional task, then introduce a legitimate revision to its source instruction. The previously prepared action should not continue as though its content and conditions are unchanged. Identify whether renewed review is needed and who is authorised to provide it.

Check changes to appointment time, recipient, clinical conditions and approved wording separately where they use different system components. A change in one field may not propagate to a generated message or an external queue. The evidence should show the actual behaviour rather than an assumed common update mechanism.

Preserve the previous version for the approved audit purpose. The current task should explain which instruction superseded it. If an action already occurred, use the appropriate correction and incident process; editing the historical approval does not undo a disclosure or a booking.

Rehearse the clinical route with the actual cover team

Use an approved synthetic example of a clinical question arriving through the administrative workflow. Verify the recognised route, responsible professional or team, acceptance evidence and handling when the first recipient is unavailable. The test must not ask an administrative model to decide treatment or invent an urgency threshold.

Check the published or communicated service availability against the roster and operating procedure. A task in a queue is not evidence of continuous clinical monitoring. The oversight design needs an available professional pathway for the scope the clinic proposes to enable.

Confirm what the patient is told through the approved communication process and what remains unresolved. Do not mark the clinical issue closed because a coordinator forwarded it. Preserve the distinction between routing, accepted responsibility, professional response and subsequent administrative action.

Make the fallback usable before the first live action

Identify the person authorised to pause the affected workflow and the systems or channels the pause covers. Test that the stop reaches queued work as well as the visible interface. Define how staff continue essential coordination through the clinic’s approved fallback without creating ungoverned copies of patient records.

List the minimum information the temporary record needs: the relevant identifier, current instruction, responsible owner, action already taken and unresolved next step. Apply appropriate access and retention arrangements. A fallback that depends on one staff member’s personal device or memory is not an operationally reliable plan.

Test a return from fallback. Reconcile what happened before restarting jobs so patients do not receive obsolete or duplicate instructions. The release record should identify who checked that reconciliation and which exceptions remain held after the rest of the workflow resumes.

Decide on a failed restriction test without averaging it away

Consider a fictional release with 14 defined checks. Thirteen pass, but a queued message still uses a recipient route that has been validly restricted. The correct decision is to block the affected release until the failure is resolved and retested, not to describe the workflow as mostly approved.

The service owner should identify the affected scope and maintain a safe approved process for current obligations. If a genuinely separate workflow can proceed, document the separation and its independent evidence. Do not assume it is separate merely because it uses a different screen in the same system.

After the fix, repeat the failed scenario and the dependent paths that could share the defect, such as retries and manual resends. Record the change and evidence. The scenario illustrates release logic; it does not claim that a particular number of tests guarantees safety.

Record the authorised decision and its conditions

Write whether the defined release may proceed, remains blocked or requires further evidence. Identify the accountable decision-maker and the domain approvals on which the decision relies. The operational owner should not imply that their signature substitutes for clinical, privacy or technical approval.

Include the accepted version, scope, unresolved non-blocking issues, monitoring arrangement and review trigger. Link the evidence actually inspected. Avoid signing an unrestricted statement such as “all follow-up automation is approved” when the tests covered one pathway at one site.

The tool evaluation checklist can support earlier comparisons. This release decision is tied to the configured workflow, trained users and current service arrangement that will perform the work.

Record how an authorised owner can withdraw or narrow the decision if a required dependency disappears. For example, loss of the accepted clinical cover may change what can operate even when the software is unchanged. Communicate the revised scope to operators and support teams, and reconcile already queued work.

Monitor the first use against the accepted boundaries

Assign responsibility for observing the approved initial operating period and reviewing exceptions. Choose measures connected to the release requirements: unsupported tasks, stale recipients, unaccepted clinical handovers and failed reconciliation. Message volume alone cannot show whether those conditions hold.

Define what findings trigger a pause, additional review or return to the authorised fallback. Use the clinic’s relevant professional and incident procedures for actual concerns. Do not promise a universal monitoring interval or assume that one successful day validates every later change.

Reopen the relevant checks when the workflow, provider, model, scope, staffing or channel arrangement changes materially. The maturity assessment can identify wider capability gaps, while this release record preserves the concrete decision about the current configuration.

Keep the evidence pack inspectable and proportionate

Store the decision, test records, reviewed configuration and approved operating instructions where the relevant authorised teams can find them. Avoid unnecessary patient data in screenshots or test evidence. An evidence pack should explain the decision without becoming a second uncontrolled clinical record.

Use the audit approach to connect a test action to the version, reviewer and result. Protect evidence from silent edits and make later corrections visible. If a reviewer cannot establish which configuration passed, the pack does not support the release it claims to document.

Retain the failed checks and their resolution, not only the final green result. They show what changed and why dependent tests were selected. A record of a prevented unsafe action can be more useful for later maintenance than a screenshot of an ordinary successful message.

Use the checklist to define the next demonstration

Select the checks that can be meaningfully explored in a fictional rehearsal and identify which require deployment evidence. Ask for a blocked task, a changed recipient and a restart scenario, with the expected result written in advance. Keep simulated evidence explicitly labelled.

The public Echo experience demonstrates review and correction of consultation-derived administrative tasks with simulated downstream actions. It cannot establish that a live clinic channel, booking interface or clinical escalation path passes this release checklist. Use fictional consultation data and assess proposed integrations separately.

Book a release-readiness walkthrough with a defined workflow and synthetic cases. The useful next step is a clear list of demonstrated evidence, unresolved blockers and named owners, leading to an accountable decision for the actual deployment.